Document:

Stock Restriction Agreement entered into with Franklin H. Moss

 EXHIBIT 10.22 
 STOCK RESTRICTION AGREEMENT 
 AGREEMENT made this 1st day of November 2001, between Infinity Pharmaceuticals, Inc., a
Delaware corporation (the “Company”), and Franklin H. Moss (the “Consultant”). 
 For valuable consideration, receipt of which is
acknowledged, the parties hereto agree as follows: 
 1. Purchase of Shares. The Company shall issue and sell to the Consultant and
the Consultant shall purchase from the Company, subject to the terms and conditions set forth in this Agreement and in the Company’s 2001 Stock Incentive Plan (the “Plan”), an aggregate of 150,000 shares (the “Shares”) of
common stock, $.0001 par value per share (“Common Stock”) of the Company at a price of $0.15 per share (the “Option Price”), purchasable as set forth in and subject to the terms and conditions of this Agreement and the Plan.

 The aggregate purchase price for the Shares shall be paid by the Consultant in accordance with the terms of the Plan and the Stock Option
Agreement issued to the Consultant thereunder. Upon receipt of payment by the Company for the Shares, the Company shall issue to the Consultant one or more certificates in the name of the Consultant for that number of Shares purchased by the
Consultant. The Consultant agrees that the Shares shall be subject to the Purchase Option set forth in Section 2 of this Agreement and the restrictions on transfer set forth in Section 4 of this Agreement. 
 2. Purchase Option. 
 (a) In the event that the Consultant ceases to provide services to the Company for any reason or no reason, with or without cause, prior to August 14, 2005, the Company shall have the right and option (the “Purchase Option”)
to purchase from the Consultant, for a sum equal to the Option Price per share, any shares then subject to the Purchase Option. All of the Shares shall be subject to the Purchase Option prior to August 14, 2002. On August 14, 2002,
one-fourth (1/4th) of such Shares will no longer be subject to the Purchase Option and at the end of each full
month thereafter, one forty-eighth (1/48th) of such Shares shall no longer be subject to the Purchase Option until
such time as all of such Shares are no longer subject to the Purchase Option. 
 (b) For purposes of this Agreement,
consulting service with the Company shall include consulting service with a parent or subsidiary of the Company or with another subsidiary of the parent of the Company. 
 3. Exercise of Purchase Option and Closing. 
 (a) The Company may exercise the
Purchase Option by delivering or mailing to the Consultant (or his estate), in accordance with Section 13, within 90 days after the termination of the service of the Consultant for the Company, a written notice of exercise of the Purchase
Option. Such notice shall specify the number of Shares to be purchased. If and to the extent the Purchase Option is not so exercised by the giving of such a notice within such 90-day period, the Purchase Option shall automatically expire and
terminate effective upon the expiration of such 90-day period. 

 (b) Within 10 days after his receipt of the Company’s notice of the exercise of the
Purchase Option pursuant to subsection (a) above, the Consultant (or his estate or any escrow agent) shall tender to the Company at its principal offices the certificate or certificates representing the Shares which the Company has elected to
purchase, duly endorsed in blank by the Consultant or with duly endorsed stock powers attached thereto, all in form suitable for the transfer of such Shares to the Company. Upon its receipt of such certificate or certificates, the Company shall pay
the aggregate Option Price therefor in the form of a check or by canceling indebtedness owed by the Consultant to the Company, or any combination thereof. 
 (c) After the time at which any Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to the Consultant on account
of such Shares or permit the Consultant to exercise any of the privileges or rights of a stockholder with respect to such Shares, but shall, in so far as permitted by law, treat the Company as the owner of such Shares. 
 (d) In the event that, due to the sale (whether by foreclosure or otherwise), transfer, assignment or other disposition of the Shares
(other than pursuant to the Company’s exercise of the Purchase Option) (each, a “Sale Event”), the Company is unable to exercise the Purchase Option with respect to any Shares for which the Purchase Option has not terminated (the
“Repurchase Shares”), the Consultant agrees to pay the Company, as liquidated damages, a sum, if any, by which the market value of the Repurchase Shares (as determined by such Sale Event) exceeds the aggregate Option Price paid for the
Repurchase Shares (the “Damage Amount”). 
 (e) The Company shall not purchase any fraction of a Share upon exercise
of the Purchase Option, and any fraction of a Share resulting from a computation made pursuant to Section 2 of this Agreement shall be rounded to the nearest whole Share (with any one-half Share being rounded upward). 
 4. Restrictions on Transfer. The Consultant shall not sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation of law or
otherwise (collectively “transfer”) any Shares, or any interest therein, that are subject to the Purchase Option, except that the Consultant may transfer such Shares to or for the benefit of any spouse, domestic partner sharing the same
household as the Consultant, sibling, child or grandchild, or to a trust for their benefit, provided that such Shares shall remain subject to this Agreement (including without limitation the restrictions on transfer set forth in this
Section 4 and the Purchase Option) and such permitted transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this
Agreement. 
 5. Effect of Prohibited Transfer. The Company shall not be required (a) to transfer on its books any of the Shares
which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement, or (b) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares shall have been so sold or
transferred. 
  

 - 2 - 

 6. Restrictive Legend. All certificates representing Shares shall have affixed thereto a legend in
substantially the following form, in addition to any other legends that may be required under federal or state securities laws: 
 “The
shares of stock represented by this certificate are subject to restrictions on transfer and an option to purchase set forth in a certain Stock Restriction Agreement between the corporation and the registered owner of these shares (or his predecessor
in interest), and such Agreement is available for inspection without charge at the office of the Secretary of the corporation.” 
 7.
Adjustments for Stock Splits, Stock Dividends, etc. 
 (a) If from time to time during the term of the Purchase Option
there is any stock split-up, stock dividend, stock distribution or other reclassification of the Common Stock of the Company, any and all new, substituted or additional securities to which the Consultant is entitled by reason of his ownership of the
Shares shall be immediately subject to the Purchase Option, the restrictions on transfer and other provisions of this Agreement in the same manner and to the same extent as the Shares, and the Option Price shall be appropriately adjusted.

 (b) If the Shares are converted into or exchanged for, or stockholders of the Company receive by reason of any distribution
in total or partial liquidation, securities of another corporation, or other property (including cash), pursuant to any merger of the Company or acquisition of its assets, then the rights of the Company under this Agreement shall inure to the
benefit of the Company’s successor and this Agreement shall apply to the securities or other property received upon such conversion, exchange or distribution in the same manner and to the same extent as the Shares. 
 8. Withholding Taxes. 
 (a) The Consultant acknowledges and agrees that the Company has the right to deduct from payments of any kind otherwise due to the Consultant any federal, state or local taxes of any kind required by law to be withheld with respect to the
purchase of the Shares by the Consultant or the lapse of the Purchase Option. 
 (b) The Consultant acknowledges that he has
been informed of the advisability of making an election in accordance with Section 83(b) of the Internal Revenue Code of 1986, as amended; that such election must be filed with the Internal Revenue Service within 30 days of the transfer of
shares to the Consultant; and that the Consultant is solely responsible for making such election. 
 9. Severability. The invalidity
or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by
law. 
 10. Waiver. Any provision contained in this Agreement may be waived, either generally or in any particular instance, by the
Board of Directors of the Company. 
 11. Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company
and the Consultant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 4 of this Agreement. 
  

 - 3 - 

 12. No Rights To Employment as a Consultant. Nothing contained in this Agreement shall be
construed as giving the Consultant any right to be retained, in any position, as a Consultant of the Company. 
 13. Notice. All
notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or upon deposit in the United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto
at the address shown beneath his or its respective signature to this Agreement, or at such other address or addresses as either party shall designate to the other in accordance with this Section 13. 
 14. Pronouns. Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter
forms, and the singular form of nouns and pronouns shall include the plural, and vice versa. 
 15. Entire Agreement. This Agreement
and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement. 
 16. Amendment. This Agreement may be amended or modified only by a written instrument executed by both the Company and the Consultant. 

17. Governing Law. This Agreement shall be construed, interpreted and enforced in accordance with the laws of The Commonwealth of
Massachusetts. 
 18. Delivery of Certificates. The Consultant authorizes the Company, on his or her behalf, to hold the stock
certificates representing the Shares until the latest of: 
  

	 	(i)	the date on which the Shares are no longer subject to the Purchase Option; 

  

	 	(ii)	the closing of an initial underwritten public offering of the Company’s securities pursuant to an effective registration statement filed by the Company under the Securities
Act; 

  

	 	(iii)	a sale of all or substantially all of the capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise; or 

  

	 	(iv)	the date which is no later than thirty days (30) after the date on which the Consultant cease ; to serve as a Consultant to the Company. 

  

 - 4 - 

 19. Escrow. The Consultant shall execute Joint Escrow Instructions in the form attached hereto as
Exhibit A simultaneously with the execution hereof. The Joint Escrow Instructions shall be delivered to the person named by the Company to serve as escrow agent thereunder. The Consultant shall simultaneously deliver to such escrow agent a
stock assignment duly endorsed in blank and hereby instructs the Company to deliver to such escrow agent, on behalf of the Consultant, the certificate(s) evidencing the Shares issued hereunder. 
 [Remainder of page intentionally left blank] 
  

 - 5 - 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above
written. 
  

			
	 INFINITY PHARMACEUTICALS, INC.

		
	By:	 	 /s/ Steven H. Holtzman

		 	 Steven H. Holtzman

		 	 President and Chief Executive Officer

			
	
	 CONSULTANT

	
	/s/ Franklin H. Moss
	 (Signature)

	
	Franklin H. Moss
	 Print Name

		
	 Address:
	 	 85 Chestnut Street
 Weston, MA 02493

	
	The undersigned co-owner of the Shares agrees by signing below to join herein and be bound by all of the terms and conditions hereof.
	
	/s/ Kimberly S. Moss
	 (Signature)

	
	Kimberly S. Moss
	 Print Name

		
	 Address:
	 	 85 Chestnut Street
 Weston, MA 02493

  

 - 6 -Form of Restricted Stock Agreement entered into with each of the officers

 Exhibit 10.23 
 Attached hereto is a form of restricted stock agreement by and among the Registrant and each of the below-named persons. The restricted stock agreement by and among the Registrant and each of the below-named persons is substantially
identical in all material respects with such form, except with respect to the details that are set forth below. 
 The number of shares and the exercise or
purchase price of each of the awards listed in the table below is presented after giving effect to the business combination between Discovery Partners International, Inc. (“Discovery Partners”) and Infinity Pharmaceuticals, Inc.
(“IPI”) in accordance with the terms of the Agreement and Plan of Merger among Discovery Partners, Darwin Corp, a wholly owned subsidiary of Discovery Partners (“Darwin Corp.”), and IPI dated as of April 11, 2006, pursuant
to which IPI merged with and into Darwin Corp. and became a wholly owned subsidiary of Discovery Partners and Discovery Partners changed its name to Infinity Pharmaceuticals, Inc. In addition, the number of shares and the exercise or purchase price
of each of the awards listed in the table below is presented after giving effect to the Registrant’s 1-for-4 reverse stock split, which became effective on September 12, 2006. 
  

									
	 Date of
 Agreement
	 	 Name
	 	 Number of Shares
 Subject to Award
	 	 Exercise/
Purchase Price
	 	 Vesting

	 3/25/04
	 	Steven Holtzman	 	   552	 	$1.72	 	(1)
					
	 5/10/05
	 	Steven Holtzman	 	1,105	 	$2.04	 	(1)
					
	 3/25/05
	 	Julian Adams	 	   130	 	$1.72	 	(1)
					
	 5/10/05
	 	Julian Adams	 	1,105	 	$2.04	 	(1)
					
	 3/25/04
	 	Adelene Perkins	 	   552	 	$1.72	 	(1)
					
	 5/10/05
	 	Adelene Perkins	 	1,105	 	$2.04	 	(1)
					
	 6/16/04
	 	Franklin Moss	 	3,453	 	$1.72	 	(1)

 (1) Each of these awards was fully vested upon grant.

 INFINITY PHARMACEUTICALS, INC. 
 Restricted Stock Agreement  
 Granted Under 2001 Stock Incentive Plan

 AGREEMENT made this          day of
                 200  , between Infinity Pharmaceuticals, Inc. a Delaware corporation (the “Company”), and
                             (the “Participant”). 
 For valuable consideration, receipt of which is acknowledged, the parties hereto agree as follows: 
 1. Purchase of Shares. 
 The Company
shall issue and sell to the Participant, and the Participant shall purchase from the Company, subject to the terms and conditions set forth in this Agreement and in the Company’s 2001 Stock Incentive Plan (the “Plan”),
                 shares (the “Shares”) of common stock, $.0001 par value, of the Company (“Common Stock”), at a purchase price of
$         per share. The aggregate purchase price for the Shares shall be paid by the Participant by check payable to the order of the Company or such other method as may be acceptable to the Company. Upon
receipt by the Company of payment for the Shares, the Company shall issue to the Participant one or more certificates in the name of the Participant for that number of Shares purchased by the Participant. The Participant agrees that the Shares shall
be subject to the purchase option set forth in Section 3 of this Agreement and the restrictions on transfer set forth in Section 2 of this Agreement. 
 2. Restrictions on Transfer. 
 (a) The Participant shall not sell, assign, transfer,
pledge, hypothecate or otherwise dispose of, by operation of law or otherwise (collectively “transfer”) any Shares, or any interest therein, except that the Participant may transfer Shares (i) to or for the benefit of any spouse,
domestic partner sharing the same household, children, parents, uncles, aunts, siblings, grandchildren and any other relatives approved by the Board of Directors (collectively, “Approved Relatives”) or to a trust established solely for the
benefit of the Participant and/or Approved Relatives, provided that such Shares shall remain subject to this Agreement (including without limitation the restrictions on transfer set forth in this Section 2, and the right of first refusal
set forth in 3) and such permitted transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement or (ii) as
part of the sale of all or substantially all of the shares of capital stock of the Company (including pursuant to a merger or consolidation), provided that, in accordance with the Plan, the securities or other property received by the
Participant in connection with such transaction shall remain subject to this Agreement. 
 (b) The Participant shall not
transfer any Shares, or any interest therein, except in accordance with Section 3 below. 

 3. Right of First Refusal. 
 (a) If the Participant proposes to transfer any Shares, then the Participant shall first give written notice of the proposed transfer (the
“Transfer Notice”) to the Company. The Transfer Notice shall name the proposed transferee and state the number of such Shares he proposes to transfer (the “Offered Shares”), the price per share and all other material terms and
conditions of the transfer. 
 (b) For 30 days following delivery to the Company of such Transfer Notice, the Company shall
have the option to purchase all (but not less than all) of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all of the Offered Shares, it shall give written notice of
such election to the Participant within such 30-day period. Within 10 days after delivery to the Participant of such notice, the Participant shall tender to the Company at its principal offices the certificate or certificates representing the
Offered Shares, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in form suitable for transfer of the Offered Shares to the Company. Promptly following receipt of such certificate or certificates,
the Company shall deliver or mail to the Participant a check in payment of the purchase price for the Offered Shares; provided that if the terms of payment set forth in the Transfer Notice were other than cash against delivery, the
Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice; and provided further that any delay in making such payment shall not invalidate the Company’s exercise of its option
to purchase the Offered Shares. 
 (c) If the Company does not elect to acquire all of the Offered Shares, the Participant
may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares to the proposed transferee, provided that such transfer shall not be on terms and
conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares transferred pursuant to this Section 3 shall remain subject to this Agreement (including without
limitation the restrictions on transfer set forth in Section 2 and the right of first refusal set forth in this Section 3) and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming
that such transferee shall be bound by all of the terms and conditions of this Agreement. 
 (d) After the time at which the
Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to the Participant on account of such Offered Shares or permit the Participant to
exercise any of the privileges or rights of a stockholder with respect to such Shares, but shall, in so far as permitted by law, treat the Company as the owner of such Offered Shares. 

 (e) The following transactions shall be exempt from the provisions of this
Section 3: 
 (1) a transfer of Shares to or for the benefit of any Approved Relatives, or to a trust established solely
for the benefit of the Participant and/or Approved Relatives; 
 (2) any transfer pursuant to an effective registration
statement filed by the Company under the Securities Act of 1933, as amended (the “Securities Act”); and 
 (3) the
sale of all or substantially all of the shares of capital stock of the Company (including pursuant to a merger or consolidation); 
 (4) provided, however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to this Agreement (including without limitation the restrictions on transfer set forth in Section 2
and the right of first refusal set forth in this Section 3) and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and
conditions of this Agreement. 
 (f) The Company may assign its rights to purchase Offered Shares in any particular
transaction under this Section 3 to one or more persons or entities. 
 (g) The provisions of this Section 3 shall
terminate upon the earlier of the following events: 
 (1) the closing of the sale of shares of Common Stock in an
underwritten public offering pursuant to an effective registration statement filed by the Company under the Securities Act; or 
 (2) the sale of all or substantially all of the capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the
individuals and entities who were beneficial owners of the Common Stock immediately prior to such transaction beneficially own, directly or indirectly, more than 75% of the outstanding securities entitled to vote generally in the election of
directors of the resulting, surviving or acquiring corporation in such transaction). 
 (h) The Company shall not be required
(i) to transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement, or (ii) to treat as owner of such Shares or to pay dividends to any transferee to
whom any such Shares shall have been so sold or transferred. 
 4. Agreement in Connection with Public Offering. 
 The Participant agrees, in connection with the initial underwritten public offering of the Company’s securities pursuant to a registration statement
under the Securities Act, (i) not to sell, make short sale of, loan, grant any options for the purchase of, or otherwise dispose of any shares of Common Stock held by the Participant (other than those shares included in the offering) without
the prior written consent of the Company or the underwriters managing such initial underwritten public offering of the Company’s securities for a period of 180 days from the effective date of such registration statement, and (ii) to
execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering. 

 5. Restrictive Legends. 
 All certificates representing Shares shall have affixed thereto legends in substantially the following form, in addition to any other legends that may be
required under federal or state securities laws: 
 “The shares of stock represented by this certificate are subject to restrictions on
transfer and an option to purchase set forth in a certain Restricted Stock Agreement between the corporation and the registered owner of these shares (or his predecessor in interest), and such Agreement is available for inspection without charge at
the office of the Secretary of the corporation.” 
 “The shares represented by this certificate have not been registered under the
Securities Act of 1933, as amended, and may not be sold, transferred or otherwise disposed of in the absence of an effective registration statement under such Act or an opinion of counsel satisfactory to the corporation to the effect that such
registration is not required.” 
 6. Provisions of the Plan. 
 (a) This Agreement is subject to the provisions of the Plan, a copy of which is furnished to the Participant with this Agreement.

 (b) As provided in the Plan, upon the occurrence of a Reorganization Event (as defined in the Plan), the repurchase and
other rights of the Company hereunder shall inure to the benefit of the Company’s successor and shall apply to the cash, securities or other property which the Shares were converted into or exchanged for pursuant to such Reorganization Event in
the same manner and to the same extent as they applied to the Shares under this Agreement. If, in connection with a Reorganization Event, a portion of the cash, securities and/or other property received upon the conversion or exchange of the Shares
is to be placed into escrow to secure indemnification or similar obligations, the mix between the vested and unvested portion of such cash, securities and/or other property that is placed into escrow shall be the same as the mix between the vested
and unvested portion of such cash, securities and/or other property that is not subject to escrow. 
 7. Investment Representations.

 The Participant represents, warrants and covenants as follows: 
 (a) The Participant is purchasing the Shares for his own account for investment only, and not with a view to, or for sale in connection
with, any distribution of the Shares in violation of the Securities Act, or any rule or regulation under the Securities Act. 

 (b) The Participant has had such opportunity as he has deemed adequate to obtain from
representatives of the Company such information as is necessary to permit him to evaluate the merits and risks of his investment in the Company. 
 (c) The Participant has sufficient experience in business, financial and investment matters to be able to evaluate the risks involved in the purchase of the Shares and to make an informed investment decision with
respect to such purchase. 
 (d) The Participant can afford a complete loss of the value of the Shares and is able to bear the
economic risk of holding such Shares for an indefinite period. 
 (e) The Participant understands that (i) the Shares
have not been registered under the Securities Act and are “restricted securities” within the meaning of Rule 144 under the Securities Act; (ii) the Shares cannot be sold, transferred or otherwise disposed of unless they are
subsequently registered under the Securities Act or an exemption from registration is then available; (iii) in any event, the exemption from registration under Rule 144 will not be available for at least one year and even then will not be
available unless a public market then exists for the Common Stock, adequate information concerning the Company is then available to the public, and other terms and conditions of Rule 144 are complied with; and (iv) there is now no registration
statement on file with the Securities and Exchange Commission with respect to any stock of the Company and the Company has no obligation or current intention to register the Shares under the Securities Act. 
 8. Withholding Taxes. 
 (a) The Participant acknowledges and agrees that the Company has the right to deduct from payments of any kind otherwise due to the Participant any federal, state or local taxes of any kind required by law to be withheld with respect to the
purchase of the Shares by the Participant or the lapse of the Purchase Option. 
 The Participant has reviewed with the Participant’s own tax advisors
the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of
its agents. The Participant understands that the Participant (and not the Company) shall be responsible for the Participant’s own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.

 9. Miscellaneous. 
 (a) No Rights to Employment. The Participant acknowledges and agrees that the transactions contemplated hereunder does not constitute an express or implied promise of continued engagement as an employee or
consultant for the vesting period, for any period, or at all. 
 (b) Severability. The invalidity or unenforceability
of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law. 

 (c) Waiver. Any provision for the benefit of the Company contained in this
Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company. 
 (d)
Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions
on transfer set forth in Sections 2 and 3 of this Agreement. 
 (e) Notice. All notices required or permitted hereunder
shall be in writing and deemed effectively given upon personal delivery or five days after deposit in the United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown beneath
his or its respective signature to this Agreement, or at such other address or addresses as either party shall designate to the other in accordance with this Section 9(e). 
 (f) Pronouns. Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine,
feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural, and vice versa. 
 (g)
Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement. 
 (h) Amendment. This Agreement may be amended or modified only by a written instrument executed by both the Company and the
Participant. 
 (i) Governing Law. This Agreement shall be construed, interpreted and enforced in accordance with the
internal laws of the State of Delaware without regard to any applicable conflicts of laws. 
 (j) Participant’s
Acknowledgments. The Participant acknowledges that he or she: (i) has read this Agreement; (ii) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice
or has voluntarily declined to seek such counsel; (iii) understands the terms and consequences of this Agreement; (iv) is fully aware of the legal and binding effect of this Agreement; and (v) understands that the law firm of Hale and
Dorr LLP, is acting as counsel to the Company in connection with the transactions contemplated by the Agreement, and is not acting as counsel for the Participant. 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above
written. 
  

			
	 INFINITY PHARMACEUTICALS, INC.

		
	 By:
	 	  
	 Name:
 Title:
	 	
		
	 Address:
	 	 780 Memorial Drive

		 	 Cambridge, MA 02139

	
	  
	 [Signature of Participant]

	
	
	 [Name of Participant]

		
	 Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]